Table 1.
Case | Agea | Sex | Drug | Dose (mg/day) | Behavioral and mood effect | Causality assignmentb | Factors supporting causal association |
---|---|---|---|---|---|---|---|
1 | 40s | Male | Simvastatin | 80 | Irritability, detachment, joylessness, anxiety, impatience, reduced social activities, depressive mood, adjustment disorder, completed suicide | Possible | R O: fatigue, insomnia, cognitive/attention problems, temperature dysregulation, skin irritation RF: high body mass index, high-dose statin Comment: tight temporal association to statin onset also supports a causal connection (completed suicide precluded an attempt at statin discontinuation) |
2 | 50s | Female | Simvastatin | 10 | Depression, joylessness, loss of appetite | Probable | R, D O: muscle weakness, muscle cramps, muscle pain, shortness of breath, fatigue/lack of energy RF: thyroid disorder, female gender |
3 | 50s | Male | Atorvastatin | 20, 10 | Depression, joylessness, hopelessness, aggression, irritability | Probable | R, D O: weight gain |
4 | 40s | Male | Atorvastatin | 10 | Depression, aggression, impatience, irritability, paranoia, completed suicide | Possible | R: possible O: memory problems, sleep problems, hearing loss, muscle pain, skin irritation |
5 | 30s | Male | Fenofibrate + rosuvastatin, atorvastatin | Unknown | Aggression, irritability, divorce | Probable | R, D O: memory problems, fatigue RF: thyroid problems, high triglycerides, fenofibrate combination |
6 | 40s | Male | Lovastatin | Unknown | Depression, mania, suicide attempts, dyscontrol of bipolar episodes | Possible | R FH (psychiatric) |
7 | Teens | Male | Atorvastatin | 20 | Depression, nightmares, anxiety, attention/concentration problems, completed suicide | Definite | R, D, RC FH (psychiatric) |
8 | 60s | Male | Simvastatin | 10 | Depression, hopelessness, aggression, irritability, loss of interest in activities and socializing, completed suicide | Possible | R O: muscle and joint pain FH (psychiatric) |
9 | 60s | Male | Simvastatin Atorvastatin |
20 10 |
Irritability, aggression, increased emotional response | Definite | R, D, RC O: memory problems, cognitive problems, skin irritation, muscle pain |
10 | 30s | Male | Atorvastatin | 10–20 40 |
Violent ideation, anxiety | Probable | R, D FH RF |
11 | 50s | Male | Atorvastatin Simvastatin |
20 20 |
Aggression, irritability | Definite | R, D, RC O: fatigue RF: hypertension |
12 | 40s | Male | Lovastatin, rosuvastatin, atorvastatin, simvastatin, pravastatinc | Varying doses (40 mg-1 mg) | Aggression, irritability, violent ideation | Definite | R, D, RC O: cognitive problems, shortness of breath, muscle pain |
D dechallenge evidence (discontinued the agent and experienced improvement), FH family history of adverse effects from cholesterol drugs, O development of other recognized adverse events of cholesterol drugs (for review of data connecting statins to these other adverse events, see Tables 1, 7, and 8 of Golomb and Evans [39]), R development of marked personality change sustained while on drug, RC rechallenge evidence (reinitiated the agent and experienced recurrence), RF other known risk factors for statin adverse events (for review of data connecting risk factors to statin adverse events, see Table 4 of Golomb and Evans [39])
aAge listed in decades for de-identification purposes due to the sensitive nature of cases
bAdverse drug reaction causality assignment was generated using the Naranjo criteria [38]
cPatient tried pravastatin but did not experience a behavioral effect